
The problem and solution

A Widespread Problem with Limited Solutions
4 out of 5 people struggle with speech and myofunctional disorders, impacting their communication, confidence, and overall health. Traditional treatments are time and travel intensive.
The Market Opportunity
The OMD’s market presents a significant opportunity for growth, as highlighted by the projected evolution from 2025 to 2028.
In 2025, the:
Total Addressable Market (TAM) evaluated at 305 million cases
Serviceable Available Market (SAM) is evaluated at 305,000 cases
Serviceable Obtainable Market (SOM) is evaluated at 2,000 cases
By 2028 these numbers are projected to grow significantly:
TAM increases slightly to over 300 millon estimated cases
SAM will be expaned to over 1.8 millon cases
SOM experiences a massive jump expected to 54,000 cases
The growing number of cases is due to the overall market growth, the aspiration of CODONIS to do geographic expansions and product diversifications but also to the increasing patient and consumer spending power.
The Market Opportunity – Estimated Value
The treatment of orofacial myofunctional disorders (OMDs), speech disorders, paresis, and cleft/palate conditions represents a significant and growing economic opportunity in the healthcare sector.

OMDs
(majority of cases)
CHF 1,500 per treatment
(based on 10 sessions)

Speech Disorders
(~15% of cases)
CHF 1,500 per treatment
(based on 10 sessions)

Paresis
(1–5% of cases)
CHF >20K
(includes therapy and surgery)

Cleft/Palate
(0.1–1% of cases)
CHF >20K
(includes therapy and surgery)
Market Size Projections
Year | TAM (Total Addressable Market) | SAM (Serviceable Available Market) | SOM (Serviceable Obtainable Market) |
---|---|---|---|
2024 | USD 37.6 bn | USD 3.76 bn | USD 5.3 mn |
2030 | USD 63.8 bn | USD 6.38 bn | USD 31.9 mn (based on 2% EU SAM) |
Key highlights:
- In 2024, the SOM is valued at USD 5.3 million.
- By 2030, the SOM grows substantially to USD 31.9 million, signaling a strong market capture potential over six years, especially within the European segment of the speech therapy market.
Segment | SOM Value (USD) | % Allocation (suggested) |
---|---|---|
OMD incl. Beauty | USD 12.8 million | 40% (Face yoga, aesthetics) |
Speech Disorders | USD 10.0 million | 31% (Clinical therapy focus) |
Paresis (Facial) | USD 6.4 million | 20% (Facial palsy, etc.) |
Cleft/Palate | USD 2.7 million | 9% (Smaller but critical) |
With increasing awareness, technological advancements, and improved access to therapy, this market holds significant untapped potential—particularly as CODONIS scales its services across the EU and North America.
The CODONIVERSE
Discover innovative solutions tailored to enhance your orofacial & myofunctional health and well-being

CODONIS ONE
An orofacial myofunctional training system for smart speech therapy. Your path to a natural smile!

CODONIS ORB
An orofacial myofunctional therapy device for the stimulation and strengthening of the orofacial muscles

CODONIS START
A fresh start to every therapy session. Start your myofunctional therapy with CODONIS START

CODONIS APP
Empower therapy experience with the CODONIS APP. Enhances the therapy experience for patients and therapists.
CODONIS ONE 3D View
An orofacial myofunctional training system for smart speech therapy. Your path to a natural smile!
CODONIS ORB 3D View
An orofacial myofunctional therapy device for the stimulation and strengthening of the orofacial muscles.
Where We're Investing
Our Strategic Focus Areas for Innovation and Growth

Device Smartification
Integrating intelligent sensors and connectivity into our therapy devices to provide real-time data and personalized feedback, optimizing patient outcomes.

Multivariable Data Analysis
Developing advanced analytics to
process and interpret patient data,
enabling predictive insights and
customized therapy plans and motivating patients.

Gamification
Designing interactive and
rewarding therapy experiences that
increase patient engagement and
promote long-term adherence
CODONIS in numbers
Driving measurable impact through innovation and care
Real People, Real Success Stories
Driving measurable impact through innovation and care
From 50 Years of Struggle to a Breath of Fresh Air:
A Transformative Therapy for a Severely Disabled Patient
Click to see the detailed Case Study

Before Therapy
This 50-year-old, severely disabled man, struggled daily with open-mouth breathing and constant drooling, causing deep discomfort and social self-consciousness.

After 4 Months of Therapy
With just 4 minutes of daily training, his mouth now stays closed, drooling has stopped, and healthy nose breathing is fully restored, bringing him confidence and an improved well-being.
A Brave 6-Year-Old’s Journey from Social Exclusion to Belonging
Click to see the detailed Case Study

Before Therapy
This sweet little girl endured constant drooling, struggled to swallow, and felt the sting of social exclusion at school, leaving her isolated and frustrated.

After 13 Weeks of Therapy
She developed stronger mouth and tongue muscles, gained complete control over her salivary flow, transformed her swallowing, and no longer needed medication, allowing her to thrive socially and build friendships at school.
Imagine Losing Your Smile: Restoring Facial Symmetry After Nerve Palsy
Click to see the detailed Case Study

Before Therapy
This resilient woman struggled with left-side facial paralysis, leading to a drooping mouth corner and difficulty closing her left eye. She also experienced dry eye and speech challenges, affecting her day-to-day life.

After 14 Weeks of Therapy
She found her smile again with full recovery of facial symmetry. Her eye and mouth movements returned to normal, and she is finally free from the dry eye and speech challenges that once troubled her.
Testimonials
See what people say about us


The team behind CODONIS
At CODONIS AG, our team brings together a wealth of knowledge and experience. Led by CEO Susanne Codoni, alongside Dr. Stefan Stübinger, Fabio Cirillo, Michael Hug and Marlène Linder Lovis, we collectively possess close to a century of expertise in speech therapy, dental diseases, and device development within this discipline.

Dr.h.c Susanne Codoni
Susanne is a dedicated speech therapist and a therapeutic expert who breaks new ground and makes a significant contribution to improving the quality of life of her clients through her innovative way of thinking and tireless commitment. She is a driving force in myofunctional therapy and is committed to making the impossible possible.

PD Dr. Stefan Stübinger
Stefan is our clinical & dental expert and has so many ideas for dental applications that even the dentist's chair is shaking with creativity.

Fabio Cirillo
Fabio is a master at turning ideas into reality, with a deep understanding of requirements, quality and engineering. His foresight guarantees that everything not only works today, but is also strategically resourceful and a perfect fit for the future

Michael Hug
Michael, with his solid dental background, is the man who seamlessly implements ideas from development to go-to-market. With his keen eye for detail and his innovative strength, he successfully brings new concepts to market

Marlène Linder Lovis
Marlène is a trainer in myofunctional therapy and is characterized by her francophone ease and methodical approach. Her well-founded contributions and ability to convey complex concepts in an understandable way contribute significantly to the further development of her colleagues' and clients' work.
CODONIS Active Therapists
Discover trusted locations with CODONIS-trained therapist where you can receive CODONIS product prescriptions.

Ready to join the future?
Contact CODONIS
Get the info you’re looking for right now.

Or Book a Call
Get in touch directly with our team for more information